Can CAR T Cell Therapy Be a Good Way of Treating Other Diseases
DOI:
https://doi.org/10.54097/br3sxm81Keywords:
CAR T cell, other diseases, treatment.Abstract
CAR T-cells (CARs) have been used to treat a variety of cancers since their discovery in the late 1980s. Because of its efficacy, it has been used as a focus of research and a breakthrough point in cancer treatment, and its principles can also be a way to treat other types of diseases. Therapeutic trials focusing on different diseases and proving its effectiveness in treating different diseases or having been put into medical trials have shown that it works as part of the immune system to treat diseases other than cancer. The ability of CARs therapy to treat other diseases has been successful in different clinical and other trials, and in the future it may be possible to combine it with other therapies or immunotherapies (such as immune checkpoint inhibitors or chemotherapy) to treat other The ability of CARs to treat other diseases may contribute to space exploration and other important steps in human history.
Downloads
References
Vita Golubovskaya. CAR-T Cells Targeting Immune Checkpoint Pathway Players. Front. Biosci. (Landmark Ed) 2022, 27(4), 121.
Han, X., Wang, Y., Wei, J. et al. Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy. J Hematol Oncol 12, 128 (2019)
Zmievskaya E, Valiullina A, Ganeeva I, Petukhov A, Rizvanov A, Bulatov E. Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections. Biomedicines. 2021; 9(1):59.
Christoph T. Ellebrecht et al.,Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.Science353,179-184(2016).
Skuljec J, Chmielewski M, Happle C, Habener A, Busse M, Abken H and Hansen G (2017) Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma. Front. Immunol. 8:1125. ]
Karin Krebs, Nina Böttinger, Li–Rung Huang, Markus Chmielewski, Silke Arzberger, Georg Gasteiger, Clemens Jäger, Edgar Schmitt, Felix Bohne, Michaela Aichler, Wolfgang Uckert, Hinrich Abken, Mathias Heikenwalder, Percy Knolle, Ulrike Protzer,T Cells Expressing a Chimeric Antigen Receptor That Binds Hepatitis B Virus Envelope Proteins Control Virus Replication in Mice,
Qi J, Ding C, Jiang X and Gao Y (2020) Advances in Developing CAR T-Cell Therapy for HIV Cure. Front. Immunol. 11:361.
Sterner, R.C., Sterner, R.M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).
Oh, S., Mao, X., Manfredo-Vieira, S. et al. Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. Nat Biotechnol 41, 1229–1238 (2023).
J. Gauthier, I. Yakoub-Agha,Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives,Current Research in Translational Medicine,
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
